THRA anticorps (N-Term)
Aperçu rapide pour THRA anticorps (N-Term) (ABIN303925)
Antigène
Voir toutes THRA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Specific for the ~50k TR-alpha 1 and the ~58k TR-alpha 2 proteins
-
Purification
- Protein G purified
-
Immunogène
- Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha 1/alpha 2-isotype.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
-
Approved: WB (1:1000)
Not recommended for: IHC-P -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 50 μLof 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol.
-
Stock
- -20 °C
-
Stockage commentaire
-
Short term: -20°C
Long term: -20°C.
-
-
- THRA (Thyroid Hormone Receptor, alpha (THRA))
-
Autre désignation
- THRA
-
Sujet
- This antibody detects: THR Alpha 1+2
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Sensory Perception of Sound, Cellular Response to Molecule of Bacterial Origin, Regulation of Lipid Metabolism by PPARalpha, Regulation of Muscle Cell Differentiation, Maintenance of Protein Location, Skeletal Muscle Fiber Development
Antigène
-